Cravatex Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022
For the full year, sales was INR 5,943.34 million compared to INR 5,318.77 million a year ago. Revenue was INR 6,042.66 million compared to INR 5,461.9 million a year ago. Net loss was INR 198.87 million compared to INR 306.09 million a year ago. Basic loss per share from continuing operations was INR 76.96 compared to INR 118.45 a year ago. Diluted loss per share from continuing operations was INR 76.96 compared to INR 118.45 a year ago.